Complications and outcomes of SARS-CoV-2 in pregnancy: where and what is the evidence?


Journal

Hypertension in pregnancy
ISSN: 1525-6065
Titre abrégé: Hypertens Pregnancy
Pays: England
ID NLM: 9421297

Informations de publication

Date de publication:
Aug 2020
Historique:
pubmed: 28 5 2020
medline: 18 7 2020
entrez: 28 5 2020
Statut: ppublish

Résumé

To add to the growing evidence on SARS-CoV-2 infection during pregnancy, so as to better inform clinical decision making and optimize patient outcomes. A systematic search of relevant databases was perfomed on 25 March 2020 and a repeat search, on 10 April 2020. Reports of pregnant patients with SARS-CoV-2 infection at any time during their pregnancy were reviewed and summarized . We summarized the outcomes of a total of 155 pregnant women and 118 neonates. The evidence suggests a similar rate of severe COVID-19 cases in pregnant women and the general population. The frequency of cesarean deliveries is high, against guidelines recommendations. Limited data on COVID-19 during preganacy, associated with a wide variation in the methodology make accurate data interpretation difficult.

Identifiants

pubmed: 32456489
doi: 10.1080/10641955.2020.1769645
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

361-369

Auteurs

Ayssa Teles Abrao Trad (A)

Maternal-Fetal Medicine Division, Department of Obstetrics and Gynecology, Mayo Clinic College of Medicine , Rochester, MN, USA.

Eniola R Ibirogba (ER)

Maternal-Fetal Medicine Division, Department of Obstetrics and Gynecology, Mayo Clinic College of Medicine , Rochester, MN, USA.

Amro Elrefaei (A)

Maternal-Fetal Medicine Division, Department of Obstetrics and Gynecology, Mayo Clinic College of Medicine , Rochester, MN, USA.

Kavita Narang (K)

Maternal-Fetal Medicine Division, Department of Obstetrics and Gynecology, Mayo Clinic College of Medicine , Rochester, MN, USA.

Gabriele Tonni (G)

Prenatal Diagnostic Unit, Department of Obstetrics and Gynaecology, AUSL Istituto Di Ricerca a Carattere Clinico Scientifico (IRCCS) Di Reggio Emilia , Reggio Emilia, Italy.

Olivier Picone (O)

Service de Gynécologie-obstétrique Colombes, Assistance publique-hôpitaux de Paris, hôpitaux Louis Mourier, Université de Paris , Colombes, France.

Anna Suy (A)

Department of Obstetrics and Gynecology, Hospital Universitari Vall d'Hebron , Barcelona, Spain.

Elena Carreras Moratonas (E)

Department of Obstetrics and Gynecology, Hospital Universitari Vall d'Hebron , Barcelona, Spain.

Mark D Kilby (MD)

Fetal Medicine Centre, Birmingham Women's and Children's Foundation NHS Trust , Birmingham, UK.
College of Medical & Dental Sciences, University of Birmingham , Birmingham, UK.

Rodrigo Ruano (R)

Maternal-Fetal Medicine Division, Department of Obstetrics and Gynecology, Mayo Clinic College of Medicine , Rochester, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH